![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 48, 48120-48128, November 28, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

¶
||
¶





¶¶
||||
From the
Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, and ¶¶Institute on Aging, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, the **Department of Biochemistry, University of Washington, Seattle, Washington 98195, 
Neurodegeneration Research Laboratory, National Neuroscience Institute, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore, and the 
Departments of Neurology and Neuroscience, The Johns Hopkins University, Baltimore, Maryland 21287
Autosomal recessive juvenile parkinsonism is a movement disorder associated with the degeneration of dopaminergic neurons in substantia nigra pars compacta. The loss of functional parkin caused by parkin gene mutations is the most common single cause of juvenile parkinsonism. Parkin has been shown to aid in protecting cells from endoplasmic reticulum and oxidative stressors presumably due to ubiquitin ligase activity of parkin that targets proteins for proteasomal degradation. However, studies on parkin have been impeded because of limited reagents specific for this protein. Here we report the generation and characterization of a panel of parkin-specific monoclonal antibodies. Biochemical analyses indicate that parkin is present only in the high salt-extractable fraction of mouse brain, whereas it is present in both the high salt-extractable and RIPA-resistant, SDS-extractable fraction in young human brain. Parkin is present at decreased levels in the high salt-extractable fraction and at increased levels in the SDS-extractable fraction from aged human brain. This shift in the extractability of parkin upon aging is seen in humans but not in mice, demonstrating species-specific differences in the biochemical characteristics of murine versus human parkin. Finally, by using these highly specific anti-parkin monoclonal antibodies, it was not possible to detect parkin in
-synuclein-containing lesions in
-synucleinopathies, thereby challenging prior inferences about the role of parkin in movement disorders other than autosomal recessive juvenile parkinsonism.
Received for publication, June 27, 2003 , and in revised form, September 3, 2003.
* This work was supported in part by NIA and NINDS grants from the National Institutes of Health and the Michael J. Fox Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Both authors contributed equally to this work.
¶ Supported by a National Institutes of Health training grant (Training in Age-related Neurodegenerative Diseases).
|| Supported by a fellowship from the Canadian Institutes of Health Research.
|||| The John H. Ware III Chair of Alzheimer's Research. To whom correspondence should be addressed. Tel.: 215-662-6427; E-mail: vmylee{at}mail.med.upenn.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. A. Olzmann, L. Li, M. V. Chudaev, J. Chen, F. A. Perez, R. D. Palmiter, and L.-S. Chin Parkin-mediated K63-linked polyubiquitination targets misfolded DJ-1 to aggresomes via binding to HDAC6 J. Cell Biol., September 7, 2007; 178(6): 1025 - 1038. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. H. Henn, L. Bouman, J. S. Schlehe, A. Schlierf, J. E. Schramm, E. Wegener, K. Nakaso, C. Culmsee, B. Berninger, D. Krappmann, et al. Parkin Mediates Neuroprotection through Activation of I{kappa}B Kinase/Nuclear Factor-{kappa}B Signaling J. Neurosci., February 21, 2007; 27(8): 1868 - 1878. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-K. Sang, H.-Y. Chang, G. M. Lawless, A. Ratnaparkhi, L. Mee, L. C. Ackerson, N. T. Maidment, D. E. Krantz, and G. R. Jackson A Drosophila Model of Mutant Human Parkin-Induced Toxicity Demonstrates Selective Loss of Dopaminergic Neurons and Dependence on Cellular Dopamine J. Neurosci., January 31, 2007; 27(5): 981 - 992. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. von Coelln, B. Thomas, S. A. Andrabi, K. L. Lim, J. M. Savitt, R. Saffary, W. Stirling, K. Bruno, E. J. Hess, M. K. Lee, et al. Inclusion body formation and neurodegeneration are parkin independent in a mouse model of alpha-synucleinopathy. J. Neurosci., April 5, 2006; 26(14): 3685 - 3696. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Uryu, C. Richter-Landsberg, W. Welch, E. Sun, O. Goldbaum, E. H. Norris, C.-T. Pham, I. Yazawa, K. Hilburger, M. Micsenyi, et al. Convergence of Heat Shock Protein 90 with Ubiquitin in Filamentous {alpha}-Synuclein Inclusions of {alpha}-Synucleinopathies Am. J. Pathol., March 1, 2006; 168(3): 947 - 961. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Matsuda, T. Kitami, T. Suzuki, Y. Mizuno, N. Hattori, and K. Tanaka Diverse Effects of Pathogenic Mutations of Parkin That Catalyze Multiple Monoubiquitylation in Vitro J. Biol. Chem., February 10, 2006; 281(6): 3204 - 3209. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wang, H. S. Ko, B. Thomas, F. Tsang, K. C.M. Chew, S.-P. Tay, M. W.L. Ho, T.-M. Lim, T.-W. Soong, O. Pletnikova, et al. Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective function Hum. Mol. Genet., December 15, 2005; 14(24): 3885 - 3897. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhang, M. Shimoji, B. Thomas, D. J. Moore, S.-W. Yu, N. I. Marupudi, R. Torp, I. A. Torgner, O. P. Ottersen, T. M. Dawson, et al. Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis Hum. Mol. Genet., July 15, 2005; 14(14): 2063 - 2073. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Whitworth, D. A. Theodore, J. C. Greene, H. Benes, P. D. Wes, and L. J. Pallanck Increased glutathione S-transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson's disease PNAS, May 31, 2005; 102(22): 8024 - 8029. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Greene, A. J. Whitworth, L. A. Andrews, T. J. Parker, and L. J. Pallanck Genetic and genomic studies of Drosophila parkin mutants implicate oxidative stress and innate immune responses in pathogenesis Hum. Mol. Genet., March 15, 2005; 14(6): 799 - 811. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Perez and R. D. Palmiter Parkin-deficient mice are not a robust model of parkinsonism PNAS, February 8, 2005; 102(6): 2174 - 2179. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yamamoto, A. Friedlein, Y. Imai, R. Takahashi, P. J. Kahle, and C. Haass Parkin Phosphorylation and Modulation of Its E3 Ubiquitin Ligase Activity J. Biol. Chem., February 4, 2005; 280(5): 3390 - 3399. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Moore, L. Zhang, J. Troncoso, M. K. Lee, N. Hattori, Y. Mizuno, T. M. Dawson, and V. L. Dawson Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress Hum. Mol. Genet., January 1, 2005; 14(1): 71 - 84. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. von Coelln, B. Thomas, J. M. Savitt, K. L. Lim, M. Sasaki, E. J. Hess, V. L. Dawson, and T. M. Dawson Loss of locus coeruleus neurons and reduced startle in parkin null mice PNAS, July 20, 2004; 101(29): 10744 - 10749. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |